Skip to main content

Table 1 Patients’ baseline characteristics

From: Metoclopramide or domperidone improves post-pyloric placement of spiral nasojejunal tubes in critically ill patients: a prospective, multicenter, open-label, randomized, controlled clinical trial

Variable Metoclopramide group Domperidone group Control group P value
( n = 100) ( n = 99) ( n = 99)
Age (years)     
 Average 62.1 ± 18.6 65.2 ± 15.1 61.3 ± 17.4 0.233
 Median 64 69 64  
 Range 18 to 93 27 to 95 20 to 96  
Male 67 (67.0) 58 (58.6) 72 (72.7) 0.107
Primary diagnosis     
 Respiratory 20 (20.0) 18 (18.2) 22 (22.2) 0.777
 Cardiovascular 5 (5.0) 10 (10.1) 9 (9.1) 0.375
 Neurological 48 (48.0) 41 (41.4) 39 (39.4) 0.439
 Sepsis 14 (14.0) 11 (11.1) 13 (13.1) 0.822
 Multitrauma 7 (7.0) 6 (6.1) 10 (10.1) 0.537
 Other 6 (6.0) 13 (13.1) 6 (6.1) 0.114
Use of sedatives 31 (31.0) 30 (30.3) 29 (29.3) 0.966
Use of analgesics 10 (10.0) 12 (12.1) 9 (9.1) 0.773
Use of vasopressors 24 (24.0) 21 (21.2) 25 (25.3) 0.790
Ventilation 72 (72.0) 66 (66.7) 68 (68.7) 0.713
Average APACHE II score 21.7 ± 7.5 20.7 ± 6.6 21.0 ± 7.3 0.582
  < 20 45 (45.0) 43 (43.4) 43 (43.4) 0.967
  ≥ 20 55 (55.0) 56 (56.6) 56 (56.6)  
Average SOFA score 9.9 ± 2.9 9.7 ± 2.8 9.7 ± 2.9 0.858
  < 12 66 (66.0) 68 (68.7) 66 (66.7) 0.916
  ≥ 12 34 (34.0) 31 (31.3) 33 (33.3)  
  1. Data presented as mean ± standard deviation, interquartile range or n (%). APACHE, Acute Physiology and Chronic Health Evaluation; SOFA, Sequential Organ Failure Assessment.